Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Colorcon
Federal Trade Commission
Citi
Moodys
Accenture
Harvard Business School
Fish and Richardson
Cipla

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205087

« Back to Dashboard
NDA 205087 describes CYPROHEPTADINE HYDROCHLORIDE, which is a drug marketed by Morton Grove, Pliva, Superpharm, Sandoz, Tg United Labs, Naska, Bio-pharm Inc, Par Pharm, Duramed Pharms Barr, Actavis Mid Atlantic, Impax Labs Inc, Kv Pharm, Zydus Pharms Usa Inc, Pioneer Pharms, Santos Biotech, Watson Labs, Appco Pharma Llc, Ailex Pharms Llc, Ivax Sub Teva Pharms, Halsey, Md Pharm, Lyne, Mylan, Apex Pharms Inc, Vitarine, Ascot, Ingenus Pharms Nj, Silarx Pharms Inc, Pharm Assoc, and Am Therap, and is included in thirty-three NDAs. It is available from twenty-five suppliers. Additional details are available on the CYPROHEPTADINE HYDROCHLORIDE profile page.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

Summary for NDA: 205087

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 205087

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYPROHEPTADINE HYDROCHLORIDE
cyproheptadine hydrochloride
TABLET;ORAL 205087 ANDA Ingenus Pharmaceuticals LLC 50742-190 50742-190-01 100 TABLET in 1 BOTTLE, PLASTIC (50742-190-01)
CYPROHEPTADINE HYDROCHLORIDE
cyproheptadine hydrochloride
TABLET;ORAL 205087 ANDA Ingenus Pharmaceuticals LLC 50742-190 50742-190-10 1000 TABLET in 1 BOTTLE, PLASTIC (50742-190-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Sep 23, 2015TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Argus Health
Healthtrust
Queensland Health
Cerilliant
QuintilesIMS
Chinese Patent Office
Farmers Insurance
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot